Evidence from multiple studies indicated that dopamine synthesis and release in the striatum (especially the associative part) was significantly enhanced, which was associated with positive symptoms in schizophrenia (64, 65), and antipsychotic medications can effectively improve these symptoms by blocking dopamine D2 receptors (15). Here, DRD2 is linked to schizophrenia.